Caca K - Search Results

1

Frequent nuclear/cytoplasmic localization of beta-catenin without exon 3 mutations in malignant melanoma.

Rimm DL, Caca K, Hu G, Harrison FB, Fearon ER. Rimm DL, et al. Among authors: caca k. Am J Pathol. 1999 Feb;154(2):325-9. doi: 10.1016/s0002-9440(10)65278-9. Am J Pathol. 1999. PMID: 10027390 Free PMC article.

2

Beta- and gamma-catenin mutations, but not E-cadherin inactivation, underlie T-cell factor/lymphoid enhancer factor transcriptional deregulation in gastric and pancreatic cancer.

Caca K, Kolligs FT, Ji X, Hayes M, Qian J, Yahanda A, Rimm DL, Costa J, Fearon ER. Caca K, et al. Cell Growth Differ. 1999 Jun;10(6):369-76. Cell Growth Differ. 1999. PMID: 10392898

3

Loss of CDX2 expression and microsatellite instability are prominent features of large cell minimally differentiated carcinomas of the colon.

Hinoi T, Tani M, Lucas PC, Caca K, Dunn RL, Macri E, Loda M, Appelman HD, Cho KR, Fearon ER. Hinoi T, et al. Among authors: caca k. Am J Pathol. 2001 Dec;159(6):2239-48. doi: 10.1016/S0002-9440(10)63074-X. Am J Pathol. 2001. PMID: 11733373 Free PMC article.

4

Netrin-1: interaction with deleted in colorectal cancer (DCC) and alterations in brain tumors and neuroblastomas.

Meyerhardt JA, Caca K, Eckstrand BC, Hu G, Lengauer C, Banavali S, Look AT, Fearon ER. Meyerhardt JA, et al. Among authors: caca k. Cell Growth Differ. 1999 Jan;10(1):35-42. Cell Growth Differ. 1999. PMID: 9950216

5

[DCC and colorectal carcinogenesis].

Caca K, Zoller WG. Caca K, et al. Z Gastroenterol. 1997 Sep;35(9):895-7. Z Gastroenterol. 1997. PMID: 9432822 German. No abstract available.

6

Neoadjuvant photodynamic therapy as a new approach to treating hilar cholangiocarcinoma: a phase II pilot study.

Wiedmann M, Caca K, Berr F, Schiefke I, Tannapfel A, Wittekind C, Mössner J, Hauss J, Witzigmann H. Wiedmann M, et al. Among authors: caca k. Cancer. 2003 Jun 1;97(11):2783-90. doi: 10.1002/cncr.11401. Cancer. 2003. PMID: 12767091 Free article. Clinical Trial.

7

Irinotecan with 5-FU/FA in advanced biliary tract adenocarcinomas: a multicenter phase II trial.

Feisthammel J, Schoppmeyer K, Mössner J, Schulze M, Caca K, Wiedmann M. Feisthammel J, et al. Among authors: caca k. Am J Clin Oncol. 2007 Jun;30(3):319-24. doi: 10.1097/01.coc.0000258124.72884.7a. Am J Clin Oncol. 2007. PMID: 17551313 Clinical Trial.

8

Extracorporeal bypassing of a partial obstruction of the afferent loop by percutaneous endoscopic jejunostomy and gastrostomy.

Caca K, Bogner JR, Eibl-Eibesfeld B, Zoller WG. Caca K, et al. Endoscopy. 1997 Feb;29(2):142-3. doi: 10.1055/s-2007-1004101. Endoscopy. 1997. PMID: 9101165 No abstract available.

9

[Endoscopy of the upper gastrointestinal tract in HIV disease].

Caca K, Zietz C, Bogner JR, Goebel FD, Zoller WG. Caca K, et al. Bildgebung. 1995 Dec;62(4):244-51. Bildgebung. 1995. PMID: 8652996 Review. German.

10

Inactivation of the INK4a/ARF locus and p53 in sporadic extrahepatic bile duct cancers and bile tract cancer cell lines.

Caca K, Feisthammel J, Klee K, Tannapfel A, Witzigmann H, Wittekind C, Mössner J, Berr F. Caca K, et al. Int J Cancer. 2002 Feb 1;97(4):481-8. doi: 10.1002/ijc.1639. Int J Cancer. 2002. PMID: 11802210

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

221 results

Search Page

Filters